All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

10

Reset

10 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • FT-4202EtavopivatPhase 36 trials

    Forma Therapeutics, Inc. · Sickle Cell Disease, Thalassemia

  • Exa-celPhase 31 trial

    Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • HBI-002Phase 22 trials

    Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell

  • TebapivatAG-946Phase 22 trials

    Agios Pharmaceuticals, Inc. · Myelodysplastic Syndromes, Sickle Cell Disease

  • AnumigilimabPhase 21 trial

    CSL Behring · Sickle Cell Disease

  • BEAM-101Phase 21 trial

    Beam Therapeutics Inc. · Sickle Cell Disease

  • BMS-986470Phase 21 trial

    Bristol Myers Squibb · Anemia, Sickle Cell, Healthy Volunteers

  • CSL889Phase 21 trial

    CSL Behring · Sickle Cell Disease Vaso-occlusive Crisis

  • ITU512Phase 21 trial

    Novartis · Sickle Cell Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.